(As of July 1, 2001, Dr. Francis Fukuyama will be
Bernard Schwartz Professor of International Political Economy at the Paul H.
Nitze School of Advanced International Studies, Johns Hopkins University. He is
currently Omer L. and Nancy Hirst Professor of Public Policy at George Mason
University)
Statement of Francis Fukuyama, Ph.D.
Thank you, Mr. Chairman, for the opportunity to
testify before this subcommittee on the subject of human cloning. I am Dr.
Francis Fukuyama, and as of July 1 of this year I will be Bernard Schwartz
Professor of International Political Economy at the Paul H. Nitze School of
Advanced International Studies, Johns Hopkins University. I have been working
intensively for the past several years on the implications of modern biology for
politics, and particularly on issues of international governance related to
biotechnology.
I am opposed to human cloning for two reasons.
The first is that human reproductive cloning, if and when it becomes possible,
will constitute a highly unnatural form of reproduction, one that interferes
with the normal process of conception and establishes a very abnormal
relationship between parent and child. I believe that human nature is a valid
standard for establishing human rights, and that technological procedures that
interfere egregiously with normal human functioning should be viewed very
skeptically in the absence of very powerful reasons to do so. I do not have time
today to defend this position at greater length, but would be happy to provide
the subcommittee with further materials at a later time.
The second reason that I am opposed to human
cloning, and in support of legislation to curtail it, is that cloning represents
the opening wedge for a series of future technologies that will permit us to
alter the human germline and ultimately to design people genetically. I believe
that we must proceed extremely cautiously in this direction because such a
capability of altering human nature has extremely grave political, social, and
moral implications. It is therefore extremely important that Congress act
legislatively at this point to establish the principle that our democratic
political community is sovereign and has the power to control the pace and scope
of such technological developments.
There is another reason for Congress to act
quickly, one that is related to our American political system. In the past, it
has been the case that the courts have stepped into controversial areas of
social policy when the legislature failed to act to negotiate acceptable
political rules. This was the case, for example, with both abortion and busing.
In the absence of Congressional action on cloning, it is conceivable that the
courts at some later point may be tempted or compelled to step into the breech
and discover, for example, that human cloning or research on cloning is a
constitutionally protected right. This has been and will be a very poor approach
to the formulation of law and public policy. The American people must therefore
express their will on human cloning at the first opportunity through their
democratically elected representatives, a will that I believe the courts will be
predisposed to respect.
Of the two bills before this committee, H.R.
1644, "The Human Cloning Prohibition Act of 2001," and H.R. 2172,
"The Cloning Prohibition Act of 2001," I would strongly urge Congress
to pass the former. The reason for this is that while both bills ban
reproductive cloning, the latter in effect legalizes non-reproductive cloning
and the deliberate creation of embryos for research purposes. I believe that
this would legitimate the first step toward the manufacture of human beings, and
I do not believe that it will be possible to enforce a ban on reproductive
cloning once embryos can be easily produced for research purposes.
The issue that I would like to raise before this
committee concerns the international dimensions of any effort to regulate a
medical technology like human cloning. Opponents of a legislative ban frequently
argue that such a ban would be rendered ineffective by the fact that we live in
a globalized world in which any attempt to regulate technology by sovereign
nation-states can easily be sidestepped by moving to another jurisdiction. There
are other advanced countries in Europe and Asia eager to move ahead in
biotechnology, it is said, and the United States will risk falling behind
technologically if we hobble ourselves by restricting either research into or
the actual procedure of cloning. In the absence of comprehensive international
regulation, no national regulation will work. This is part of a larger
widespread belief that technological advance should not and cannot be stopped.
I believe that this is a fundamentally flawed
argument. In the first place, it is simply not the case that the pace and scope
of technological advance cannot be controlled politically. There are many
dangerous or controversial technologies, including nuclear weapons and nuclear
power, ballistic missiles, biological and chemical warfare agents, replacement
human body parts, neuropharmacological drugs, and the like which cannot be
freely developed or traded internationally. We have successfully regulated
experimentation in human subjects internationally for many decades. The fact
that none of the regulatory regimes controlling these technologies has ever been
leakproof or regulations fully implemented has never been a valid reason not to
try to put them in place in the first instance.
Second, to argue that no national ban or
regulation can precede an international agreement on the subject is to put the
cart before the horse. Regulation never starts at an international level:
nation-states have to set up enforceable rules for their own societies before
they can even begin to think about international rules. The United States, as an
economically, politically, and culturally dominant force in the world will have
an enormous impact on other societies. The Council on Europe has already passed
a ban on cloning; to date, twenty-four countries (including Germany, France,
Italy, and Japan) have already enacted national bans on cloning, while sixteen
have banned creation of embryos for research purposes. The United States can do
a great deal to either reinforce (or else undermine) an emerging international
consensus that human cloning is an unacceptable use of medical technology.
I do believe that international competition in
biomedical research creates problems for any nation that wants to limit or
control new technology. There are a number of countries that will try to exploit
a human cloning ban or any other constraints the United States places on the
development of future biotechnologies. We should not be prematurely defeatist,
however, in thinking that we have no choice but to join in this technological
arms race. If we can establish a general consensus among civilized nations that
human cloning is unacceptable, we will then have a range of traditional
diplomatic and economic instruments at our disposal to persuade or pressure
countries outside that consensus to join. If human cloning ends up being a
procedure that can be performed, but only in states regarded as renegade or
pariahs, then so much the better. But none of this will be possible unless we
first begin by establishing laws on this subject for the United States.
Let me close by saying that human cloning is the
first of many political decisions and battles that will occur over
biotechnology. In the future, total bans on research and technology development
of the sort envisioned by H. R. 1644 will not be the right model. What we will
soon need is a broader regulatory structure that will permit us, on a routine
basis, to make decisions that distinguish between those technologies that
represent positive and helpful advances for human well-being, and those that
raise troubling moral and political questions. Ultimately, this regulation will
have to become international in scope if it is to be more effective. We will
need to think carefully about the institutional form that such a regulatory
structure must take. A blanket ban on human cloning is appropriate at this time,
however, because it is necessary at an early point to establish the principle
that the political community has the legitimacy, authority, and power to control
the direction of future biomedical research, on an issue where it is difficult
to come up with compelling arguments about why there is a legitimate need for
human cloning.
Thank you very much for your attention.